BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Z, He YL, Cai SR, Zhan WH, Li ZR, Zhu BH, Chen CQ, Ma JP, Chen ZX, Li W. Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference. Int J Cancer. 2008;123:1439-1447. [PMID: 18561324 DOI: 10.1002/ijc.23643] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Labbé DP, Hardy S, Tremblay ML. Protein tyrosine phosphatases in cancer: friends and foes! Prog Mol Biol Transl Sci. 2012;106:253-306. [PMID: 22340721 DOI: 10.1016/B978-0-12-396456-4.00009-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
2 Ustaalioglu BB, Bilici A, Barisik NO, Aliustaoglu M, Vardar FA, Yilmaz BE, Seker M, Gumus M. Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer. Clin Transl Oncol. 2012;14:911-922. [PMID: 22855168 DOI: 10.1007/s12094-012-0880-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
3 Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Waraya M, Kawamata H, Nishimiya H, Nakamura K, Watanabe M. Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer. BMC Cancer. 2011;11:122. [PMID: 21466710 DOI: 10.1186/1471-2407-11-122] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
4 Dong Q, Ding X, Chang B, Wang H, Wang A. PRL-3 promotes migration and invasion and is associated with poor prognosis in salivary adenoid cystic carcinoma. J Oral Pathol Med 2016;45:111-8. [PMID: 26041460 DOI: 10.1111/jop.12331] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
5 Xu Y, Sun J, Xu J, Li Q, Guo Y, Zhang Q. miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer. Gastroenterol Res Pract. 2012;2012:640168. [PMID: 22792096 DOI: 10.1155/2012/640168] [Cited by in Crossref: 21] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
6 Radke I, Götte M, Smollich M, Scharle N, Kiesel L, Wülfing P. Expression of PRL-3 regulates proliferation and invasion of breast cancer cells in vitro. Arch Gynecol Obstet 2017;296:1153-60. [PMID: 28980126 DOI: 10.1007/s00404-017-4542-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
7 Chi Y, Wang X, Yang Y, Zhang C, Ertl HC, Zhou D. Survivin-targeting Artificial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft Models. Mol Ther Nucleic Acids 2014;3:e208. [PMID: 25368912 DOI: 10.1038/mtna.2014.59] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
8 Ren S, Zhou Y, Fang X, She X, Wu Y, Wu X. PRL-3 Is Involved in Estrogen- and IL-6-Induced Migration of Endometrial Stromal Cells From Ectopic Endometrium. Reprod Sci 2017;24:124-32. [PMID: 27222233 DOI: 10.1177/1933719116650751] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Fleischmann A, Rocha C, Saxer-Sekulic N, Zlobec I, Sauter G, Thalmann GN. High-level cytoplasmic cyclin D1 expression in lymph node metastases from prostate cancer independently predicts early biochemical failure and death in surgically treated patients. Histopathology 2011;58:781-9. [PMID: 21438905 DOI: 10.1111/j.1365-2559.2011.03800.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
10 Wei Z, Xia G, Wu Y, Chen W, Xiang Z, Schwarz RE, Brekken RA, Awasthi N, He Y, Zhang C. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer. Cancer Letters 2015;359:335-43. [DOI: 10.1016/j.canlet.2015.01.033] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 7.9] [Reference Citation Analysis]
11 Zhang C, Tian W, Meng L, Qu L, Shou C. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis. J Mol Med (Berl) 2016;94:401-15. [PMID: 26548949 DOI: 10.1007/s00109-015-1350-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
12 Nakayama N, Yamashita K, Tanaka T, Kawamata H, Ooki A, Sato T, Nakamura T, Watanabe M. Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis. Clin Exp Metastasis 2016;33:3-13. [PMID: 26563151 DOI: 10.1007/s10585-015-9749-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
13 Zhou J, Wang S, Lu J, Li J, Ding Y. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma. Int J Cancer 2009;124:1879-86. [PMID: 19101992 DOI: 10.1002/ijc.24096] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
14 Ng L, Poon RTP, Pang R. Biomarkers for predicting future metastasis of human gastrointestinal tumors. Cell Mol Life Sci 2013;70:3631-56. [DOI: 10.1007/s00018-013-1266-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
15 Julien SG, Dubé N, Hardy S, Tremblay ML. Inside the human cancer tyrosine phosphatome. Nat Rev Cancer 2011;11:35-49. [PMID: 21179176 DOI: 10.1038/nrc2980] [Cited by in Crossref: 315] [Cited by in F6Publishing: 305] [Article Influence: 28.6] [Reference Citation Analysis]
16 Yamashita K, Sakuramoto S, Watanabe M. Genomic and epigenetic profiles of gastric cancer: Potential diagnostic and therapeutic applications. Surg Today 2011;41:24-38. [DOI: 10.1007/s00595-010-4370-5] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 5.1] [Reference Citation Analysis]
17 Hardy S, Kostantin E, Hatzihristidis T, Zolotarov Y, Uetani N, Tremblay ML. Physiological and oncogenic roles of the PRL phosphatases. FEBS J 2018;285:3886-908. [DOI: 10.1111/febs.14503] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
18 Chang W, Ma L, Lin L, Gu L, Liu X, Cai H, Yu Y, Tan X, Zhai Y, Xu X, Zhang M, Wu L, Zhang H, Hou J, Wang H, Cao G. Identification of novel hub genes associated with liver metastasis of gastric cancer. Int J Cancer 2009;125:2844-53. [DOI: 10.1002/ijc.24699] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
19 Ibberson D, Benes V, Muckenthaler MU, Castoldi M. RNA degradation compromises the reliability of microRNA expression profiling. BMC Biotechnol 2009;9:102. [PMID: 20025722 DOI: 10.1186/1472-6750-9-102] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 5.9] [Reference Citation Analysis]
20 Bilici A, Ustaalioglu BB, Yavuzer D, Seker M, Mayadagli A, Gumus M. Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy. Dig Dis Sci 2012;57:1568-75. [PMID: 22331511 DOI: 10.1007/s10620-012-2076-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
21 Dai N, Lu AP, Shou CC, Li JY. Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer. World J Gastroenterol 2009; 15(12): 1499-1505 [PMID: 19322925 DOI: 10.3748/wjg.15.1499] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
22 Xiong JB, Li DJ, Jie ZG, Chen HP, Li ZR. Role of phosphatase of regenerating liver 3 in gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2016; 24(1): 59-66 [DOI: 10.11569/wcjd.v24.i1.59] [Reference Citation Analysis]
23 Xing X, Lian S, Hu Y, Li Z, Zhang L, Wen X, Du H, Jia Y, Zheng Z, Meng L. Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma. J Transl Med. 2013;11:309. [PMID: 24330843 DOI: 10.1186/1479-5876-11-309] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
24 Calloni R, Bonatto D. Scaffolds for Artificial miRNA Expression in Animal Cells. Hum Gene Ther Methods 2015;26:162-74. [PMID: 26406928 DOI: 10.1089/hgtb.2015.043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
25 Chen H, Wang X, Bai J, He A. Expression, regulation and function of miR-495 in healthy and tumor tissues. Oncol Lett 2017;13:2021-6. [PMID: 28454357 DOI: 10.3892/ol.2017.5727] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
26 Thura M, Al-Aidaroos AQO, Yong WP, Kono K, Gupta A, Lin YB, Mimura K, Thiery JP, Goh BC, Tan P, Soo R, Hong CW, Wang L, Lin SJ, Chen E, Rha SY, Chung HC, Li J, Nandi S, Yuen HF, Zhang SD, Guan YK, So J, Zeng Q. PRL3-zumab, a first-in-class humanized antibody for cancer therapy. JCI Insight 2016;1:e87607. [PMID: 27699276 DOI: 10.1172/jci.insight.87607] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
27 Jin Z, Selaru FM, Cheng Y, Kan T, Agarwal R, Mori Y, Olaru AV, Yang J, David S, Hamilton JP. MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene. 2011;30:1577-1585. [PMID: 21119604 DOI: 10.1038/onc.2010.534] [Cited by in Crossref: 82] [Cited by in F6Publishing: 89] [Article Influence: 6.8] [Reference Citation Analysis]
28 Ichikawa D, Kubota T, Kikuchi S, Fujiwara H, Konishi H, Tsujiura M, Ikoma H, Nakanishi M, Okamoto K, Sakakura C, Ochiai T, Kokuba Y, Otsuji E. Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer. J Surg Oncol. 2009;100:111-114. [PMID: 19475584 DOI: 10.1002/jso.21311] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
29 Xiong J, Li Z, Zhang Y, Li D, Zhang G, Luo X, Jie Z, Liu Y, Cao Y, Le Z, Tan S, Zou W, Gong P, Qiu L, Li Y, Wang H, Chen H. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN. Oncol Rep 2016;36:1819-28. [PMID: 27572739 DOI: 10.3892/or.2016.5030] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
30 Guo X, Jing C, Li L, Zhang L, Shi Y, Wang J, Liu J, Li C. Down-regulation of VEZT gene expression in human gastric cancer involves promoter methylation and miR-43c. Biochem Biophys Res Commun 2011;404:622-7. [PMID: 21156161 DOI: 10.1016/j.bbrc.2010.12.026] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
31 Xu M, Cao Y, Jiang MM, Jie ZG, Li ZR. MiR495- and miR551a-mediated down-regulation of PRL-3 expression inhibits peritoneal metastasis in a mouse model of gastric cancer. Shijie Huaren Xiaohua Zazhi 2013; 21(18): 1693-1700 [DOI: 10.11569/wcjd.v21.i18.1693] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
32 Xu J, Zhang C, He Y, Wu H, Wang Z, Song W, Li W, He W, Cai S, Zhan W. Lymphatic endothelial cell-secreted CXCL1 stimulates lymphangiogenesis and metastasis of gastric cancer. Int J Cancer. 2012;130:787-797. [PMID: 21387301 DOI: 10.1002/ijc.26035] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
33 Mu N, Gu J, Liu N, Xue X, Shu Z, Zhang K, Huang T, Chu C, Zhang W, Gong L, Zhao H, Jia B, Gao D, Shang L, Zhang W, Guo Q. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways. Theranostics 2018;8:1527-39. [PMID: 29556339 DOI: 10.7150/thno.22699] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
34 Sultan S, Alzahrani N, Al-Sakkaf K. The postpartum effect of maternal diabetes on the circulating levels of sirtuins and superoxide dismutase. FEBS Open Bio 2018;8:256-63. [PMID: 29435415 DOI: 10.1002/2211-5463.12370] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern M, Rosenfeld N, Chajut A, Niv Y, Kushnir M. MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol 2011; 17(35): 3976-3985 [PMID: 22046085 DOI: 10.3748/wjg.v17.i35.3976] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.1] [Reference Citation Analysis]
36 Jiang MM, Cao Y, Li ZR, Jie ZG. Suppressive effect of miR495 and miR551a on PRL-3 expression in gastric cancer SGC7901 cells. Shijie Huaren Xiaohua Zazhi 2012; 20(34): 3361-3365 [DOI: 10.11569/wcjd.v20.i34.3361] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Orsatti L, Forte E, Tomei L, Caterino M, Pessi A, Talamo F. 2-D Difference in gel electrophoresis combined with Pro-Q Diamond staining: A successful approach for the identification of kinase/phosphatase targets. ELECTROPHORESIS 2009;30:2469-76. [DOI: 10.1002/elps.200800780] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
38 Hao R, Zhang X, Pan Y, Liu H, Xiang Y, Wan L, Wu X. Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer. J Cancer Res Clin Oncol 2010;136:1349-57. [DOI: 10.1007/s00432-010-0786-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]